Journal
ANNALS OF NUCLEAR MEDICINE
Volume 32, Issue 3, Pages 217-235Publisher
SPRINGER
DOI: 10.1007/s12149-018-1230-7
Keywords
Lu-177-DOTA-TATE; Radionuclide therapy; Neuroendocrine tumor
Funding
- Health Labour Sciences Research Grant [H26-Iryo-Ippan-019]
Ask authors/readers for more resources
Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177-DOTA-TATE treatment in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown in this guideline are considered internationally useful as well. Only the original Japanese version is the formal document.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available